Clinical Trial Update: Implementing PrEP for Women Who Inject Drugs [NA]

View source ↗

Summary

Clinical trial update on implementing pre-exposure prophylaxis (PrEP) for women who inject drugs; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Substance Use Disorder

Drugs mentioned

• Truvada (emtricitabine/tenofovir disoproxil fumarate) (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: University of Pennsylvania | Conditions: HIV, Intravenous Substance Abuse | NA | Status: ACTIVE_NOT_RECRUITING